aspirin has been researched along with Hemolysis in 74 studies
Aspirin: The prototypical analgesic used in the treatment of mild to moderate pain. It has anti-inflammatory and antipyretic properties and acts as an inhibitor of cyclooxygenase which results in the inhibition of the biosynthesis of prostaglandins. Aspirin also inhibits platelet aggregation and is used in the prevention of arterial and venous thrombosis. (From Martindale, The Extra Pharmacopoeia, 30th ed, p5)
acetylsalicylate : A benzoate that is the conjugate base of acetylsalicylic acid, arising from deprotonation of the carboxy group.
acetylsalicylic acid : A member of the class of benzoic acids that is salicylic acid in which the hydrogen that is attached to the phenolic hydroxy group has been replaced by an acetoxy group. A non-steroidal anti-inflammatory drug with cyclooxygenase inhibitor activity.
Hemolysis: The destruction of ERYTHROCYTES by many different causal agents such as antibodies, bacteria, chemicals, temperature, and changes in tonicity.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The use of aspirin, as part of a dual antiplatelet therapy regimen, is an established standard following coronary stenting in patients suffering from acute coronary syndrome (ACS)." | 8.95 | Aspirin safety in glucose-6-phosphate dehydrogenase deficiency patients with acute coronary syndrome undergoing percutaneous coronary intervention. ( Al Hout, AR; Feghaly, J; Mercieca Balbi, M, 2017) |
| "Hemolysis was not observed after incubation with ASA alone but was quickly noted after exposure to ASA (25 mg/100 ml) and H2O2 (1." | 5.26 | Aspirin-induced hemolysis: the role of concomitant oxidant (H2O2) challenge. ( Lubin, B; Oski, FA; Stockman, JA, 1978) |
| "The use of aspirin, as part of a dual antiplatelet therapy regimen, is an established standard following coronary stenting in patients suffering from acute coronary syndrome (ACS)." | 4.95 | Aspirin safety in glucose-6-phosphate dehydrogenase deficiency patients with acute coronary syndrome undergoing percutaneous coronary intervention. ( Al Hout, AR; Feghaly, J; Mercieca Balbi, M, 2017) |
| " Chronic gastric ulcer in rats was modeled using glacial acetic acid." | 3.96 | A new derivative of acetylsalicylic acid and carnosine: synthesis, physical and chemical properties, biological activity. ( Andreeva, LA; Fedorova, TN; Kulichenkova, KN; Kulikova, OI; Lopachev, AV; Lopacheva, OM; Migulin, VA; Nagaev, IY; Stvolinsky, SL; Trubitsina, IE, 2020) |
| "One week after treatment with intravenously administered immune globulin and aspirin, a child with Kawasaki disease had persistent fever and an increase in coronary artery diameter to greater than 3 mm." | 3.68 | Immune hemolysis, disseminated intravascular coagulation, and serum sickness after large doses of immune globulin given intravenously for Kawasaki disease. ( Berkman, EM; Comenzo, RL; Fulton, DR; Malachowski, ME; Meissner, HC, 1992) |
| "Forty-four patients with Mediterranean-type glucose-6-phosphate dehydrogenase (G-6-PD) deficiency receiving long-term, low-dose aspirin were monitored over three months for evidence of hemolysis." | 3.68 | Long-term, low-dose aspirin is safe in glucose-6-phosphate dehydrogenase deficiency. ( Shalev, O, 1991) |
| " In five cases, temporary reversal of the HELLP syndrome was achieved using low-dose aspirin and corticosteroids." | 3.68 | Prolongation of premature gestation in women with hemolysis, elevated liver enzymes and low platelets. A report of five cases. ( Burke, MS; Heyborne, KD; Porreco, RP, 1990) |
| "Anaemia in diabetes mellitus (DM) and/or chronic renal failure (CRF) may be caused by a decreased production of erythropoietin (EPO), EPO resistance, and by the lysis of the young circulating red blood cells (neocytolysis) induced by subclinical inflammation and low EPO level." | 2.73 | Single dose of acetylsalicylic acid in patients with Type 2 diabetes mellitus and/or chronic renal failure ameliorates anaemia by decreasing the rate of neocytolysis. ( Köszegi, T; Laczy, B; Markó, L; Mohás, M; Molnár, GA; Nagy, J; Tamaskó, M; Wagner, L; Wagner, Z; Wittmann, I, 2007) |
| "G6PD deficiency is typically asymptomatic and many CVD patients with this enzyme defect start to take long-term aspirin therapy without G6PD activity examination; however, no consensus on the safety of aspirin in this population has been reached." | 2.72 | Aspirin Therapy in Cardiovascular Disease with Glucose-6-Phosphate Dehydrogenase Deficiency, Safe or Not? ( Chen, C; Chen, J; Chen, Y; Jiang, Z; Li, J; Li, P; Liang, J; Ou, Z; Ouyang, F; Wei, J; Zeng, J, 2021) |
| "Most conventional ophthalmic dosage forms, though simplistic are limited by poor bioavailability in the posterior chamber of the eye." | 1.38 | Protein based nanoparticles as platforms for aspirin delivery for ophthalmologic applications. ( Banerjee, R; Bellare, JR; Das, S, 2012) |
| "Aspirin pretreatment had no effect on plasma ATP concentrations." | 1.34 | Human plasma ATP concentration. ( Buffington, CW; Feigl, EO; Gorman, MW, 2007) |
| "Aspirin-treated blood perfused under normoxic conditions showed a marked decrease in thrombus with a concomitant increase in both platelet adhesion and covered surface percentages." | 1.30 | Impaired antiplatelet effects of aspirin associated with hypoxia and ATP release from erythrocytes. Studies in a system with flowing human blood. ( Bozzo, J; Escolar, G; Galán, AM; Heras, M; Hernández, MR; Ordinas, A, 1999) |
| "Eleven of these children developed acute renal insufficiency." | 1.28 | Drug-induced haemolysis and renal failure in children with glucose-6-phosphate dehydrogenase deficiency in Afghanistan. ( Choudhry, VP; Fazel, I; Ghafary, A; Ghani, R; Qureshi, MA; Zaher, M, 1990) |
| "Hemolysis was not observed after incubation with ASA alone but was quickly noted after exposure to ASA (25 mg/100 ml) and H2O2 (1." | 1.26 | Aspirin-induced hemolysis: the role of concomitant oxidant (H2O2) challenge. ( Lubin, B; Oski, FA; Stockman, JA, 1978) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 48 (64.86) | 18.7374 |
| 1990's | 9 (12.16) | 18.2507 |
| 2000's | 7 (9.46) | 29.6817 |
| 2010's | 7 (9.46) | 24.3611 |
| 2020's | 3 (4.05) | 2.80 |
| Authors | Studies |
|---|---|
| Kulikova, OI | 1 |
| Stvolinsky, SL | 1 |
| Migulin, VA | 1 |
| Andreeva, LA | 1 |
| Nagaev, IY | 1 |
| Lopacheva, OM | 1 |
| Kulichenkova, KN | 1 |
| Lopachev, AV | 1 |
| Trubitsina, IE | 1 |
| Fedorova, TN | 1 |
| Kwiatek, D | 1 |
| Mrówczyńska, L | 1 |
| Stopikowska, N | 1 |
| Runowski, M | 1 |
| Lesicki, A | 1 |
| Lis, S | 1 |
| Li, J | 1 |
| Chen, Y | 1 |
| Ou, Z | 1 |
| Ouyang, F | 1 |
| Liang, J | 1 |
| Jiang, Z | 1 |
| Chen, C | 1 |
| Li, P | 1 |
| Chen, J | 1 |
| Wei, J | 1 |
| Zeng, J | 1 |
| Feghaly, J | 1 |
| Al Hout, AR | 1 |
| Mercieca Balbi, M | 1 |
| Szőke, K | 1 |
| Czompa, A | 1 |
| Lekli, I | 1 |
| Szabados-Fürjesi, P | 1 |
| Herczeg, M | 1 |
| Csávás, M | 1 |
| Borbás, A | 1 |
| Herczegh, P | 1 |
| Tósaki, Á | 1 |
| Amekoudi, EY | 1 |
| Sabi, KA | 1 |
| Noto Kadou Kaza, B | 1 |
| Lee, M | 1 |
| Wathier, M | 1 |
| Love, JA | 1 |
| McGeer, E | 1 |
| McGeer, PL | 1 |
| Kimura, M | 1 |
| Kanazawa, H | 1 |
| Kawamura, A | 1 |
| Yamamoto, T | 1 |
| Egashira, T | 1 |
| Kohno, T | 1 |
| Maekawa, Y | 1 |
| Sano, M | 1 |
| Fukuda, K | 1 |
| Amzal, H | 1 |
| Alaoui, K | 1 |
| Tok, S | 1 |
| Errachidi, A | 1 |
| Charof, R | 1 |
| Cherrah, Y | 1 |
| Benjouad, A | 1 |
| Slaughter, MS | 1 |
| Sobieski, MA | 1 |
| Graham, JD | 1 |
| Pappas, PS | 1 |
| Tatooles, AJ | 1 |
| Koenig, SC | 1 |
| Das, S | 1 |
| Bellare, JR | 1 |
| Banerjee, R | 1 |
| Gorman, MW | 1 |
| Feigl, EO | 1 |
| Buffington, CW | 1 |
| Wittmann, I | 1 |
| Molnár, GA | 1 |
| Wagner, L | 1 |
| Köszegi, T | 1 |
| Wagner, Z | 1 |
| Laczy, B | 1 |
| Tamaskó, M | 1 |
| Markó, L | 1 |
| Mohás, M | 1 |
| Nagy, J | 1 |
| Smedema, JP | 1 |
| Abrahams, S | 1 |
| Louw, VJ | 1 |
| Marceau, F | 1 |
| Hugli, TE | 1 |
| Seeler, RA | 1 |
| Luken, JA | 1 |
| McMillan, DE | 1 |
| Utterback, NG | 1 |
| Wujek, JJ | 1 |
| Minta, JO | 1 |
| Urowitz, MB | 1 |
| Smythe, HA | 1 |
| Isenman, DE | 1 |
| Guth, PH | 1 |
| Paulsen, G | 1 |
| Hirabayashi, K | 1 |
| Häussinger, G | 1 |
| Pfennigs, H | 1 |
| Chelapurath, A | 1 |
| Reul, H | 1 |
| Essers, U | 1 |
| Colonna, P | 1 |
| Gullikson, GW | 1 |
| Sender, M | 1 |
| Bass, P | 1 |
| García Rafanell, J | 1 |
| Bellés, L | 1 |
| Sánchez, MS | 1 |
| Forn, J | 1 |
| Okamoto, S | 1 |
| Görög, P | 1 |
| Kovács, IB | 1 |
| Hänsch, GM | 1 |
| Römer, W | 1 |
| Voigtländer, V | 1 |
| Rother, U | 1 |
| Wirth, PW | 1 |
| Watson, ES | 1 |
| ElSohly, M | 1 |
| Turner, CE | 1 |
| Murphy, JC | 1 |
| Machlin, LJ | 1 |
| Gabriel, E | 1 |
| Horn, LR | 1 |
| Woo, D | 1 |
| Filipski, R | 1 |
| Brin, M | 1 |
| Nelson, J | 1 |
| Sheremet'ev, IuA | 1 |
| Shtykhno, IuM | 1 |
| Udovichenko, VI | 1 |
| Levin, GIa | 1 |
| Sugimoto, N | 1 |
| Haque, A | 1 |
| Horiguchi, Y | 1 |
| Matsuda, M | 1 |
| Hsia, N | 1 |
| Everse, J | 1 |
| Bozzo, J | 1 |
| Hernández, MR | 1 |
| Galán, AM | 1 |
| Heras, M | 1 |
| Ordinas, A | 1 |
| Escolar, G | 1 |
| Ali, NA | 1 |
| al-Naama, LM | 1 |
| Khalid, LO | 1 |
| Azari, M | 1 |
| Boose, JA | 1 |
| Burhop, KE | 1 |
| Camacho, T | 1 |
| Catarello, J | 1 |
| Darling, A | 1 |
| Ebeling, AA | 1 |
| Estep, TN | 1 |
| Pearson, L | 1 |
| Guzder, S | 1 |
| Herren, J | 1 |
| Ogle, K | 1 |
| Paine, J | 1 |
| Rohn, K | 1 |
| Sarajari, R | 1 |
| Sun, CS | 1 |
| Zhang, L | 1 |
| Katoh, M | 1 |
| Karasawa, T | 1 |
| Doi, H | 1 |
| Odawara, A | 1 |
| Rezaei Kalantari, H | 1 |
| Bridges, KR | 1 |
| Schmidt, GJ | 1 |
| Jensen, M | 1 |
| Cerami, A | 1 |
| Bunn, HF | 1 |
| Rothschild, BM | 1 |
| Stockman, JA | 1 |
| Lubin, B | 1 |
| Oski, FA | 1 |
| Hattori, A | 1 |
| Jinbo, C | 1 |
| Iizumi, T | 1 |
| Ito, S | 1 |
| Matsuoka, M | 1 |
| Chan, TK | 1 |
| Todd, D | 1 |
| Tso, SC | 1 |
| Glader, BE | 2 |
| Dale, J | 1 |
| Myhre, E | 1 |
| Rootwelt, K | 1 |
| Beall, CL | 1 |
| Pierce, LE | 1 |
| Comenzo, RL | 1 |
| Malachowski, ME | 1 |
| Meissner, HC | 1 |
| Fulton, DR | 1 |
| Berkman, EM | 1 |
| Choudhry, VP | 1 |
| Ghafary, A | 1 |
| Zaher, M | 1 |
| Qureshi, MA | 1 |
| Fazel, I | 1 |
| Ghani, R | 1 |
| Shalev, O | 1 |
| Galettis, P | 1 |
| Norton, RS | 1 |
| Heyborne, KD | 1 |
| Burke, MS | 1 |
| Porreco, RP | 1 |
| Bhaskar Rao, A | 1 |
| Sisodia, P | 1 |
| Sattur, PB | 1 |
| O'Brien, JR | 2 |
| Roubal, Z | 1 |
| Grimová, J | 1 |
| Nĕmecek, O | 1 |
| Cepelák, V | 1 |
| Jobin, F | 1 |
| DeLage, JM | 1 |
| Allen, JE | 1 |
| Valeri, CR | 1 |
| Huntsman, RG | 1 |
| Lehmann, H | 1 |
| Reyers-Degli Innocenti, I | 1 |
| Poggi, A | 1 |
| de Gaetano, G | 1 |
| Barnes, AJ | 1 |
| Gutteridge, JM | 1 |
| Stocks, J | 1 |
| Dormandy, TL | 1 |
| Wiedeman, MP | 1 |
| Di Perri, T | 1 |
| Auteri, A | 1 |
| Fujimura, H | 1 |
| Tsurumi, K | 1 |
| Abe, A | 1 |
| Hayashi, M | 1 |
| Nakano, K | 1 |
| Dawson, AA | 1 |
| Walker, W | 1 |
| Sofia, RD | 1 |
| Delgado, CJ | 1 |
| Douglas, JF | 1 |
| Sheppard, H | 1 |
| Tsien, WH | 1 |
| Burghardt, C | 1 |
| Kalbhen, DA | 1 |
| Gelderblom, P | 1 |
| Domenjoz, R | 1 |
| Necheles, TF | 1 |
| Steinberg, MH | 1 |
| Cameron, D | 1 |
| Baumes, RM | 1 |
| Shahidi, NT | 1 |
| Fujihira, E | 2 |
| Otomo, S | 2 |
| Mizushima, Y | 1 |
| Sakai, S | 1 |
| Yamaura, M | 1 |
| Nakanishi, M | 1 |
| Imamura, H | 1 |
| Ikegami, K | 1 |
| Goto, K | 1 |
| Brown, JH | 1 |
| Mackey, HK | 1 |
5 reviews available for aspirin and Hemolysis
| Article | Year |
|---|---|
Aspirin Therapy in Cardiovascular Disease with Glucose-6-Phosphate Dehydrogenase Deficiency, Safe or Not?
Topics: Aspirin; Cardiovascular Diseases; Glucosephosphate Dehydrogenase Deficiency; Hemoglobins; Hemolysis; | 2021 |
Aspirin safety in glucose-6-phosphate dehydrogenase deficiency patients with acute coronary syndrome undergoing percutaneous coronary intervention.
Topics: Acute Coronary Syndrome; Aspirin; Female; Glucosephosphate Dehydrogenase Deficiency; Hemolysis; Huma | 2017 |
[How I treat ... sickle cell anemia: current therapies].
Topics: Anemia, Sickle Cell; Anti-Inflammatory Agents, Non-Steroidal; Anticoagulants; Antisickling Agents; A | 2001 |
Hematologic perturbations associated with salicylate.
Topics: Aspirin; Blood Platelets; Gastrointestinal Hemorrhage; Hematologic Diseases; Hematopoietic System; H | 1979 |
Prostaglandins in hematology.
Topics: Animals; Aspirin; Blood Coagulation; Blood Platelets; Blood Preservation; Blood Transfusion; Chromiu | 1974 |
1 trial available for aspirin and Hemolysis
| Article | Year |
|---|---|
Single dose of acetylsalicylic acid in patients with Type 2 diabetes mellitus and/or chronic renal failure ameliorates anaemia by decreasing the rate of neocytolysis.
Topics: Aged; Anemia; Aspirin; Cross-Sectional Studies; Diabetes Mellitus, Type 2; Erythropoietin; Female; H | 2007 |
68 other studies available for aspirin and Hemolysis
| Article | Year |
|---|---|
A new derivative of acetylsalicylic acid and carnosine: synthesis, physical and chemical properties, biological activity.
Topics: Acetic Acid; Animals; Anti-Ulcer Agents; Antioxidants; Aspirin; Carnosine; Erythrocytes; Hemolysis; | 2020 |
Surface Modification of Luminescent Ln
Topics: Aspirin; Biocompatible Materials; Cell Membrane Permeability; Dose-Response Relationship, Drug; Eryt | 2020 |
A new, vasoactive hybrid aspirin containing nitrogen monoxide-releasing molsidomine moiety.
Topics: Animals; Aspirin; Cell Line; Coronary Circulation; Erythrocytes; Female; Heart; Heart Rate; Hemolysi | 2019 |
[Profound anemia, hemoglobinuria ... where to stop in the etiological investigation?].
Topics: Acute Kidney Injury; Adolescent; Anemia, Hemolytic; Aspirin; Blackwater Fever; Erythrocyte Transfusi | 2014 |
Inhibition of aberrant complement activation by a dimer of acetylsalicylic acid.
Topics: Alzheimer Disease; Animals; Aspirin; Aurintricarboxylic Acid; Benzhydryl Compounds; Cats; Cells, Cul | 2015 |
Simultaneous transcatheter closure of an atrial septal defect and patent ductus arteriosus in an adult case, followed by thrombocytopenia and subclinical hemolysis.
Topics: Aged; Aspirin; Cardiac Catheterization; Ductus Arteriosus, Patent; Female; Heart Septal Defects, Atr | 2016 |
Protective effect of saponins from Argania spinosa against free radical-induced oxidative haemolysis.
Topics: Acetaminophen; Animals; Aspirin; Cells, Cultured; Erythrocytes; Free Radicals; Hemoglobins; Hemolysi | 2008 |
Platelet activation in heart failure patients supported by the HeartMate II ventricular assist device.
Topics: Aged; Anticoagulants; Aspirin; Biomarkers; CD40 Ligand; Creatinine; Cross-Sectional Studies; Female; | 2011 |
Protein based nanoparticles as platforms for aspirin delivery for ophthalmologic applications.
Topics: Animals; Aspirin; Cattle; Delayed-Action Preparations; Drug Carriers; Drug Stability; Erythrocytes; | 2012 |
Human plasma ATP concentration.
Topics: 1-Methyl-3-isobutylxanthine; Adenosine Triphosphate; Adult; Aged; Aspirin; Blood Chemical Analysis; | 2007 |
Partial reversal of hemolysis-associated pulmonary arterial hypertension in response to oral administration of L-arginine in a patient with hereditary spherocytosis.
Topics: Administration, Oral; Anti-Inflammatory Agents, Non-Steroidal; Anticoagulants; Arginine; Aspirin; He | 2007 |
Effect of C3a and C5a anaphylatoxins on guinea-pig isolated blood vessels.
Topics: Anaphylatoxins; Animals; Aspirin; Blood Vessels; Chromones; Complement C3; Complement C3a; Complemen | 1984 |
Hemolysis in ARF in a G6PD-deficient patient: case 2.
Topics: Aspirin; Child; Glucosephosphate Dehydrogenase Deficiency; Hemolysis; Humans; Male; Rheumatic Fever | 1984 |
Effect of anionic amphophiles on erythrocyte properties.
Topics: Aspirin; Benzenesulfonates; Blood Sedimentation; Blood Viscosity; Calcium Dobesilate; Erythrocytes; | 1983 |
Effect on the human complement system of the major non-steroidal anti-inflammatory drugs: aspirin, indomethacin, phenylbutazone, oxyphenbutazone and sulindac.
Topics: Anti-Inflammatory Agents; Aspirin; Centrifugation, Density Gradient; Chromatography, Gel; Complement | 1983 |
Prostaglandin cytoprotection. Prostaglandin does not protect against aspirin- or alcohol-induced red blood cell hemolysis.
Topics: Animals; Aspirin; Cell Membrane; Erythrocytes; Ethanol; Hemolysis; Male; Prostaglandins E, Synthetic | 1983 |
[Influence of platelet aggregation inhibitors on platelet damage at prosthetic heart valves in-vitro (author's transl)].
Topics: Aspirin; Blood Platelets; Dipyridamole; Heart Valve Prosthesis; Hemolysis; Humans; Lysine; Platelet | 1981 |
Aspirin and glucose-6-phosphate dehydrogenase deficiency.
Topics: Aspirin; Child; Glucosephosphate Dehydrogenase Deficiency; Hemolysis; Humans; Male | 1981 |
Laxative-like effects of nonsteroidal anti-inflammatory drugs on intestinal fluid movement and membrane integrity.
Topics: Alprostadil; Animals; Anti-Inflammatory Agents; Aspirin; Body Fluids; Cathartics; Cricetinae; Diarrh | 1982 |
[Pharmacological and biochemical study of a new non-narcotic analgesic: fosfosal (UR-1521)].
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Capillary Permeability; Cattle; Edema; Fe | 1981 |
[Experimental study of cerebral vasospasm -biochemical analysis of vasoconstrictor in the red blood cell hemolysate and the mechanism of action (author's transl)].
Topics: Animals; Aspirin; Basilar Artery; Cats; Dogs; Erythrocytes; Hemolysis; Ischemic Attack, Transient; V | 1982 |
Impaired red cell deformability in established adjuvant arthritic disease in rats.
Topics: Animals; Arthritis; Arthritis, Experimental; Aspirin; Erythrocytes; Hemolysis; Hot Temperature; Hydr | 1980 |
Effect of salicylates on the complement system: generation of mediators in vivo and in vitro.
Topics: Animals; Aspirin; Cell Migration Inhibition; Chemotaxis; Complement C3; Complement C5; Complement Sy | 1981 |
Anti-inflammatory properties of cannabichromene.
Topics: Animals; Anti-Inflammatory Agents; Aspirin; Benzopyrans; Cannabinoids; Edema; Erythrocyte Membrane; | 1980 |
Effects of aspirin and related drugs in vitamin E-deficient rats.
Topics: Animals; Aspirin; Blood Cell Count; Female; Fetal Death; Hematocrit; Hemoglobins; Hemolysis; Male; P | 1980 |
[Effect of acetylsalicylic acid and pentoxifylline (trental) on intravascular erythrocyte aggregation stimulated by arachidonic acid].
Topics: Animals; Arachidonic Acids; Aspirin; Erythrocyte Aggregation; Hemolysis; In Vitro Techniques; Pentox | 1980 |
Coronary vasoconstriction is the most probable cause of death of rats intoxicated with botulinolysin, a hemolysin produced by Clostridium botulinum.
Topics: Animals; Aspirin; Blood Pressure; Botulinum Toxins; Botulism; Clostridium botulinum; Electrocardiogr | 1995 |
The cytotoxic activities of human hemoglobin and diaspirin crosslinked hemoglobin.
Topics: Animals; Aspirin; Blood Substitutes; Cytotoxins; Hemoglobin A; Hemoglobins; Hemolysis; Macrophage Ac | 1996 |
Impaired antiplatelet effects of aspirin associated with hypoxia and ATP release from erythrocytes. Studies in a system with flowing human blood.
Topics: Adenosine Triphosphate; Animals; Aorta; Aspirin; Blood Gas Analysis; Cell Hypoxia; Erythrocyte Defor | 1999 |
Haemolytic potential of three chemotherapeutic agents and aspirin in glucose-6-phosphate dehydrogenase deficiency.
Topics: Anti-Bacterial Agents; Antimalarials; Aspirin; Case-Control Studies; Chloramphenicol; Drug Evaluatio | 1999 |
Evaluation and validation of virus removal by ultrafiltration during the production of diaspirin crosslinked haemoglobin (DCLHb).
Topics: Animals; Aspirin; Bacteriophage phi X 174; Cell Line; Diarrhea Viruses, Bovine Viral; Drug Contamina | 2000 |
Effects of the antiplatelet agent TA-993 and its metabolite MB3 on the hemorheological properties of rat and human erythrocytes.
Topics: Animals; Aspirin; Blood Viscosity; Diltiazem; Dose-Response Relationship, Drug; Erythrocytes; Hemoly | 2001 |
The acetylation of hemoglobin by aspirin. In vitro and in vivo.
Topics: Acetylation; Aspirin; Autoradiography; Binding Sites; Blood Protein Electrophoresis; Carbon Radioiso | 1975 |
Aspirin-induced hemolysis: the role of concomitant oxidant (H2O2) challenge.
Topics: Adult; Aspirin; Erythrocyte Membrane; Erythrocytes; Gentisates; Glucosephosphate Dehydrogenase; Glut | 1978 |
A scanning electron microscope study on hemostatic reaction. Early hemostatic plug formation and the effect of aspirin.
Topics: Animals; Aspirin; Blood Platelets; Carotid Arteries; Collagen; Endothelium; Erythrocytes; Glutaral; | 1975 |
Drug-induced haemolysis in glucose-6-phosphate dehydrogenase deficiency.
Topics: Aspirin; Cell Survival; China; Glucosephosphate Dehydrogenase Deficiency; Hemolysis; Humans; Male; N | 1976 |
Evaluation of the hemolytic role of aspirin in glucose-6-phosphate dehydrogenase deficiency.
Topics: Aspirin; Bilirubin; Child; Erythrocytes; Female; Gentisates; Glucosephosphate Dehydrogenase Deficien | 1976 |
Effects of dipyridamole and acetylsalicylic acid on platelet functions in patients with aortic ball-valve prostheses.
Topics: Aortic Valve; Aspirin; Blood Platelets; Cell Survival; Dipyridamole; Half-Life; Heart Valve Prosthes | 1975 |
Intravascular coagulation in acute lupus erythematosus.
Topics: Acute Disease; Adult; Aspirin; Disseminated Intravascular Coagulation; Female; Headache; Hemolysis; | 1975 |
Salicylate-induced injury of pyruvate-kinase-deficient erythrocytes.
Topics: Adenosine Triphosphate; Anemia, Hemolytic; Aspirin; Erythrocytes; Glucose; Glucosephosphate Dehydrog | 1976 |
Immune hemolysis, disseminated intravascular coagulation, and serum sickness after large doses of immune globulin given intravenously for Kawasaki disease.
Topics: ABO Blood-Group System; Aspirin; Disseminated Intravascular Coagulation; Hemolysis; Humans; Immunogl | 1992 |
Drug-induced haemolysis and renal failure in children with glucose-6-phosphate dehydrogenase deficiency in Afghanistan.
Topics: Acute Kidney Injury; Adolescent; Afghanistan; Antimalarials; Aspirin; Child; Child, Preschool; Chlor | 1990 |
Long-term, low-dose aspirin is safe in glucose-6-phosphate dehydrogenase deficiency.
Topics: Adult; Aspirin; Glucosephosphate Dehydrogenase Deficiency; Hemolysis; Humans; Male; Middle Aged; Saf | 1991 |
Biochemical and pharmacological studies of the mechanism of action of tenebrosin-C, a cardiac stimulatory and haemolytic protein from the sea anemone, Actinia tenebrosa.
Topics: Animals; Arachidonic Acid; Arachidonic Acids; Aspirin; Cardiotonic Agents; Cnidaria; Guinea Pigs; He | 1990 |
Prolongation of premature gestation in women with hemolysis, elevated liver enzymes and low platelets. A report of five cases.
Topics: Adrenal Cortex Hormones; Adult; Aspirin; Female; Hemolysis; Humans; Hypertension; Liver; Pregnancy; | 1990 |
Erythrocyte membrane stabilization by enfenamic acid.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Erythrocyte Membrane; Hemolysis; Humans; In Vitro | 1987 |
Platelet function: a guide to platelet membrane structure.
Topics: Adenosine Diphosphate; Aspirin; Blood Platelets; Cell Membrane; Cell Membrane Permeability; Cocaine; | 1970 |
Effects of nonsteroid anti-inflammatory agents and some dicoumarol derivatives on platelet aggregation, fibrinolysis and stabilization of cell membrane in vitro.
Topics: Anti-Inflammatory Agents; Aspirin; Blood Platelets; Cell Membrane; Chloroquine; Coumarins; Depressio | 1972 |
Aspirin and prednisone in microangiopathic haemolytic anaemia.
Topics: Adult; Anemia, Hemolytic; Aspirin; Blood Platelet Disorders; Blood Urea Nitrogen; Erythrocytes, Abno | 1970 |
Treatment of sickle-cell disease.
Topics: Anemia, Sickle Cell; Anesthesia; Anticoagulants; Aspirin; Bicarbonates; Blood; Blood Flow Velocity; | 1974 |
Platelet aggregation and haemolysis induced in rats by intravenous infusion of ADP - effect of potentially antithrombotic drugs.
Topics: Adenosine Diphosphate; Animals; Aspirin; Depression, Chemical; Female; Hemoglobins; Hemolysis; Infus | 1974 |
Haemolytic syndrome associated with a red cell lipid abnormality.
Topics: Adult; Aldehydes; Anemia, Hemolytic; Arachidonic Acids; Aspirin; Chromatography, Gas; Codeine; Eryth | 1973 |
Platelet aggretates induced by red blood cell injury.
Topics: Animals; Arteries; Aspirin; Chiroptera; Erythrocytes; Hemolysis; Hot Temperature; Lasers; Perfusion; | 1973 |
[Anti-complement activity in vitro and in vivo of some non-steroid anti-inflammatory drugs].
Topics: Animals; Anti-Inflammatory Agents; Aspirin; Complement Inactivator Proteins; Flufenamic Acid; Hemoly | 1973 |
[Pharmacological studies of N-benzoyl-N'-phenyl-2,6-diaminobenzoic acid (F1). 3. Interaction with proteins].
Topics: Aminopyrine; Animals; Anti-Inflammatory Agents; Arthritis; Aspirin; Benzoates; Benzyl Compounds; Blo | 1973 |
Blood and neoplastic diseases. Blood formation and the pathogenesis of anaemia.
Topics: Adolescent; Adult; Aged; Anemia; Anemia, Hypochromic; Anemia, Macrocytic; Aspirin; Bilirubin; Bone M | 1974 |
The effects of various naturally occurring cannabinoids on hypotonic-hyperthermic lysis of rat erythrocytes.
Topics: Animals; Aspirin; Cannabis; Cell Membrane; Dose-Response Relationship, Drug; Dronabinol; Erythrocyte | 1974 |
Effect of drugs on the hemolysis of rat erythrocytes.
Topics: Animals; Aspirin; Bile Acids and Salts; Chlordiazepoxide; Chloroquine; Chlorpromazine; Chlorprothixe | 1969 |
Cell membrane damage, platelet stickiness and some effects of aspirin.
Topics: Adenine Nucleotides; Aspirin; Blood Coagulation; Blood Platelets; Cell Membrane; Erythrocytes; Hemol | 1969 |
Effects of antirheumatic drugs on human erythrocyte membranes.
Topics: Aminobenzoates; Analgesics; Antipyrine; Aspirin; Barbiturates; Benzoates; Cell Membrane; Erythrocyte | 1970 |
Erythrocyte glutathione-peroxidase deficiency.
Topics: Adolescent; Adult; Anemia, Hemolytic, Congenital; Aspirin; Child; Child, Preschool; Erythrocytes; Gl | 1970 |
[Blood donors. Importance of systematic detection of GPD (glucosephosphate-6-dehydrogenase) deficiency].
Topics: Ascorbic Acid; Aspirin; Blood Donors; Glucosephosphate Dehydrogenase Deficiency; Hemolysis; Humans; | 1970 |
Drug-induced hemolysis: biochemical considerations.
Topics: Acetanilides; Anemia, Hemolytic; Aspirin; Biotransformation; Erythrocytes; Glucosephosphate Dehydrog | 1970 |
[Stabilizing effect of anti-inflammatory drugs on erythrocyte membrane. II. On UV-induced canine erythrocyte hemolysisand lipid peroxidation, on UV-induced peroxide formation in extracted lipid, and on irradiated lipid-induced hemolysis].
Topics: Animals; Anti-Inflammatory Agents; Aspirin; Betamethasone; Capillary Permeability; Chloroquine; Dogs | 1970 |
[Stabilizing effect of anti-inflammatory drugs on erythrocyte membrane. I. On hemolysis and lipid peroxidation induced by H202 in canine erythrocyte].
Topics: Animals; Anti-Inflammatory Agents; Aspirin; Betamethasone; Cell Membrane; Chloroquine; Dogs; Erythro | 1970 |
Mode of stabilizing action of non-steroid anti-inflammatory drugs on erythrocyte membrane.
Topics: Aminopyrine; Animals; Anti-Inflammatory Agents; Aspirin; Blood Coagulation; Cell Membrane; Dogs; Ery | 1970 |
Pharmacological investigations of 2-amino-3-ethoxycarbonyl-6-benzyl-4,5,6,7-tetrahydrothieno[2,3-c]pyridine.
Topics: Acid Phosphatase; Analgesics; Animals; Anti-Inflammatory Agents; Antibody Formation; Aspirin; Blood | 1970 |
Further studies on the erythrocyte anti-inflammatory assay.
Topics: Adrenal Cortex Hormones; Anti-Inflammatory Agents; Aspirin; Dimethyl Sulfoxide; Erythrocytes; Estrog | 1968 |